The Impact of Myasthenia Gravis in the Real World
The Impact of Myasthenia Gravis in the Real World
An international, non-interventional, prospective, community recruited, longitudinal,
 lifestyle study which aims to collect Real-World Evidence (RWE) from people living with
 myasthenia gravis (MG) in order to map the disease's natural history, its burden on patients
 and their families, its treatment, as well as its medical, social and pharmacoeconomic
 impact.
Data will be collected from people with MG using the MyRealWorld™ RWE platform , developed by
 the healthcare digital research company, Vitaccess. Participants will download a 'bring your
 own device' (BYOD) study app, MyRealWorld™ MG, onto their smartphones, which they will use to
 enter data and complete surveys about their MG.
Inclusion Criteria:

 -  Adults (aged 18 years and over) with any stage and any subtype of myasthenia gravis
 disease

 -  Resident in Belgium, Canada, France, Germany, Italy, Japan, Spain, the UK or the USA

 Exclusion Criteria:

 -  No specific exclusion criteria